Site‐Specific MicroRNA‐33 Antagonism by pH‐Responsive Nanotherapies for Treatment of Atherosclerosis via Regulating Cholesterol Efflux and Adaptive Immunity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Site‐Specific MicroRNA‐33 Antagonism by pH‐Responsive Nanotherapies for Treatment of Atherosclerosis via Regulating Cholesterol Efflux and Adaptive Immunity
Authors
Keywords
-
Journal
ADVANCED FUNCTIONAL MATERIALS
Volume 30, Issue 42, Pages 2002131
Publisher
Wiley
Online
2020-08-28
DOI
10.1002/adfm.202002131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunity and Inflammation in Atherosclerosis
- (2019) Dennis Wolf et al. CIRCULATION RESEARCH
- Delivery of microRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux In Vitro and In Vivo
- (2019) My-Anh Nguyen et al. ACS Nano
- Nanoparticle Therapy for Vascular Diseases
- (2019) Alyssa M. Flores et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy
- (2019) Thijs J. Beldman et al. ACS Nano
- Surface Engineered Polymersomes for Enhanced Modulation of Dendritic Cells During Cardiovascular Immunotherapy
- (2019) Sijia Yi et al. ADVANCED FUNCTIONAL MATERIALS
- Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species
- (2019) Tina Binderup et al. Science Translational Medicine
- Drug-induced liver injury
- (2019) Raul J. Andrade et al. Nature Reviews Disease Primers
- Atherosclerosis
- (2019) Peter Libby et al. Nature Reviews Disease Primers
- A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases
- (2019) Runjun Zhang et al. BIOMATERIALS
- An apoptotic body-biomimic liposome in situ upregulates anti-inflammatory macrophages for stabilization of atherosclerotic plaques
- (2019) Yue Wu et al. JOURNAL OF CONTROLLED RELEASE
- Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment
- (2018) Wei Lv et al. ACS Nano
- Regulatory T cells as a new therapeutic target for atherosclerosis
- (2018) Han-xiao Ou et al. ACTA PHARMACOLOGICA SINICA
- Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases
- (2018) Kye S. Kim et al. ANTIOXIDANTS & REDOX SIGNALING
- Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis
- (2018) Manse Kim et al. JOURNAL OF CONTROLLED RELEASE
- Nanoplumbers: biomaterials to fight cardiovascular diseases
- (2018) Flavio Dormont et al. Materials Today
- Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression
- (2018) Yanhong Guo et al. EBioMedicine
- A Targeting Nanotherapy for Abdominal Aortic Aneurysms
- (2018) Juan Cheng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis
- (2017) Amr Alaarg et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr−/− Mice
- (2017) Mikyung Yu et al. Advanced Healthcare Materials
- Angiogenesis in the atherosclerotic plaque
- (2017) Caroline Camaré et al. Redox Biology
- Non-affinity factors modulating vascular targeting of nano- and microcarriers
- (2016) Jacob W. Myerson et al. ADVANCED DRUG DELIVERY REVIEWS
- Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation inApoE−/−MiceSignificance
- (2016) Soichi Nakashiro et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Nanoparticles responsive to the inflammatory microenvironment for targeted treatment of arterial restenosis
- (2016) Shibin Feng et al. BIOMATERIALS
- Vascular Smooth Muscle Cells in Atherosclerosis
- (2016) Martin R. Bennett et al. CIRCULATION RESEARCH
- MicroRNA Regulation of Atherosclerosis
- (2016) Mark W. Feinberg et al. CIRCULATION RESEARCH
- Imaging the Permeable Endothelium
- (2016) Claudia Calcagno et al. Circulation-Cardiovascular Imaging
- Functions of microRNA-33a/b and microRNA therapeutics
- (2016) Koh Ono Journal of Cardiology
- Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines
- (2016) Pingping Xu et al. JOURNAL OF CONTROLLED RELEASE
- Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice
- (2016) Yin Dou et al. JOURNAL OF CONTROLLED RELEASE
- Statin-Associated Side Effects
- (2016) Paul D. Thompson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- In vitro and ex vivo strategies for intracellular delivery
- (2016) Martin P. Stewart et al. NATURE
- Mechanism of hard-nanomaterial clearance by the liver
- (2016) Kim M. Tsoi et al. NATURE MATERIALS
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction
- (2016) Hendrik B. Sager et al. Science Translational Medicine
- Bioresponsive materials
- (2016) Yue Lu et al. Nature Reviews Materials
- Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE–/– Mice
- (2015) Azadeh Kheirolomoom et al. ACS Nano
- MicroRNA-33–dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis
- (2015) Mireille Ouimet et al. JOURNAL OF CLINICAL INVESTIGATION
- SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides
- (2015) Jung Sun Yoo et al. Scientific Reports
- Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation
- (2015) J. Tang et al. Science Advances
- Nanocarriers for Vascular Delivery of Anti-Inflammatory Agents
- (2014) Melissa D. Howard et al. Annual Review of Pharmacology and Toxicology
- Atherosclerotic Plaque Destabilization
- (2014) Carlos Silvestre-Roig et al. CIRCULATION RESEARCH
- MicroRNA Control of High-Density Lipoprotein Metabolism and Function
- (2014) Katey J. Rayner et al. CIRCULATION RESEARCH
- MicroRNA-Management of Lipoprotein Homeostasis
- (2014) Xinghui Sun et al. CIRCULATION RESEARCH
- HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
- (2014) Anand Rohatgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis
- (2014) Y. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
- (2014) Nan Wang et al. Frontiers in Immunology
- Therapeutic Silencing of MicroRNA-33 Inhibits the Progression of Atherosclerosis in Ldlr −/− Mice—Brief Report
- (2013) Noemi Rotllan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxel
- (2013) Hongmei He et al. BIOMATERIALS
- Extracellular Acidosis Is a Novel Danger Signal Alerting Innate Immunity via the NLRP3 Inflammasome
- (2013) Kristiina Rajamäki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice
- (2013) Takahiro Horie et al. Nature Communications
- MicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE −/− Mice
- (2013) Takahiro Horie et al. Journal of the American Heart Association
- microRNA Regulation of Inflammatory Responses
- (2012) Ryan M. O'Connell et al. Annual Review of Immunology
- MicroRNA-33 in atherosclerosis etiology and pathophysiology
- (2012) Wu-Jun Chen et al. ATHEROSCLEROSIS
- Facile Engineering of Biocompatible Materials with pH-Modulated Degradability
- (2011) Jianxiang Zhang et al. ADVANCED MATERIALS
- Regulatory T cells and Foxp3
- (2011) Alexander Y. Rudensky IMMUNOLOGICAL REVIEWS
- Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
- (2011) Katey J. Rayner et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
- (2011) Katey J. Rayner et al. NATURE
- Atherosclerosis: current pathogenesis and therapeutic options
- (2011) Christian Weber et al. NATURE MEDICINE
- Perspectives and opportunities for nanomedicine in the management of atherosclerosis
- (2011) Mark E. Lobatto et al. NATURE REVIEWS DRUG DISCOVERY
- miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
- (2011) A. Davalos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the linear correlation between diffusion coefficient and molecular weight. A model to estimate diffusion coefficients in acetonitrile solutions
- (2010) Drochss P. Valencia et al. ELECTROCHEMISTRY COMMUNICATIONS
- MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
- (2010) S. H. Najafi-Shoushtari et al. SCIENCE
- MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
- (2010) K. J. Rayner et al. SCIENCE
- Integrins
- (2008) Rita Silva et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Acetal-Derivatized Dextran: An Acid-Responsive Biodegradable Material for Therapeutic Applications
- (2008) Eric M. Bachelder et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started